• 咨询热线
    客服服务热线 13671568941/15317326293
  • 在线咨询
  • 微信客服
    微信客服
  • 公众号
    扫码关注公众号

Olorofim

CAS No. 1928707-56-5

Olorofim ( —— )

产品货号. M34247 CAS No. 1928707-56-5

Olorofim(F-901318)is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM), but little inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against a variety of pathogenic filamentous and dimorphic fungi, such as Penicillium spp, P. dermatitidis spp and Fusarium spp.

纯度: >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
规格 价格/人民币 库存 数量
5MG ¥6071 有现货
10MG ¥8246 有现货
25MG ¥11625 有现货
50MG ¥14787 有现货
100MG ¥17640 有现货
500MG ¥35280 有现货
1G 获取报价 有现货

生物学信息

  • 产品名称
    Olorofim
  • 注意事项
    本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
  • 产品简述
    Olorofim(F-901318)is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM), but little inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against a variety of pathogenic filamentous and dimorphic fungi, such as Penicillium spp, P. dermatitidis spp and Fusarium spp.
  • 产品描述
    Olorofim(F-901318)is a novel selective antifungal compound targeting pyrimidine biosynthesis in mycobacteria, with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM), but little inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against a variety of pathogenic filamentous and dimorphic fungi, such as Penicillium spp, P. dermatitidis spp and Fusarium spp.
  • 体外实验
    ——
  • 体内实验
    ——
  • 同义词
    ——
  • 通路
    Metabolic Enzyme/Protease
  • 靶点
    Dehydrogenase
  • 受体
    Dehydrogenase | Antifungal
  • 研究领域
    ——
  • 适应症
    ——

化学信息

  • CAS Number
    1928707-56-5
  • 分子量
    498.55
  • 分子式
    C28H27FN6O2
  • 纯度
    >98% (HPLC)
  • 溶解度
    ——
  • SMILES
    C(C(NC1=CC=C(C=C1)N2CCN(CC2)C=3N=CC(F)=CN3)=O)(=O)C4=C(C=C(C)N4C)C5=CC=CC=C5
  • 化学全称
    ——

运输与储存

  • 储存条件
    (-20℃)
  • 运输条件
    With Ice Pack
  • 稳定性
    ≥ 2 years

参考文献

产品手册
关联产品
  • DHODH-IN-23

    DHODH-IN-23 (Compound A) 是一种具有口服活性的 DHODH 抑制剂,可用于癌症的研究。

  • G6PDi-1 B

    G6PDi-1 是一种可逆的非竞争性6-磷酸葡萄糖脱氢酶 (G6PD) 抑制剂,对人 G6PD IC50 为 0.07 μM。G6PDi-1 最强烈地消耗淋巴细胞中的 NADPH。G6PDi-1 显着降低 T 细胞中炎性细胞因子的产生。

  • 11β-HSD1-IN-11

    11β-HSD1-IN-11 (Compound c1a) 是一种竞争性的 11β-HSD1 抑制剂,对大鼠和人的 11β-HSD1 的 IC50 分别为 0.34 μM 和 0.13 μM。